Financial Architects (New Jersey)’s PDL BioPharma, Inc. PDLI Stock Holding History

Financial Architects (New Jersey)’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-500	Closed	-$1K	–	850
2020 Q2	$1K	Hold	500	–	–	﹤0.01%	837
2020 Q1	$1K	Hold	500	–	–	﹤0.01%	836
2019 Q4	$2K	Hold	500	–	–	﹤0.01%	859
2019 Q3	$1K	Hold	500	–	–	﹤0.01%	988
2019 Q2	$2K	Sell	500 -3,000	-86%	-$9.73K	﹤0.01%	1115
2019 Q1	$13K	Hold	3,500	–	–	﹤0.01%	1038
2018 Q4	$10K	Hold	3,500	–	–	﹤0.01%	1007
2018 Q3	$9K	Hold	3,500	–	–	﹤0.01%	1152
2018 Q2	$8K	Hold	3,500	–	–	﹤0.01%	1061
2018 Q1	$10K	Hold	3,500	–	–	﹤0.01%	1096
2017 Q4	$9K	Hold	3,500	–	–	﹤0.01%	1190
2017 Q3	$12K	Hold	3,500	–	–	﹤0.01%	1095
2017 Q2	$8K	Hold	3,500	–	–	﹤0.01%	1198
2017 Q1	$8K	Hold	3,500	–	–	﹤0.01%	1202
2016 Q4	$7K	Hold	3,500	–	–	﹤0.01%	1111
2016 Q3	$12K	Hold	3,500	–	–	﹤0.01%	971
2016 Q2	$11K	Buy	3,500 +3,000	+600%	+$10K	﹤0.01%	967
2016 Q1	$2K	Buy	+500	New	+$1.56K	﹤0.01%	1116
2015 Q3	–	Sell	-500	Closed	-$3K	–	1199
2015 Q2	$3K	Buy	+500	New	+$3.35K	﹤0.01%	1085
2015 Q1	–	Sell	-500	Closed	-$4K	–	1101
2014 Q4	$4K	Hold	500	–	–	﹤0.01%	892
2014 Q3	$4K	Hold	500	–	–	﹤0.01%	792
2014 Q2	$5K	Buy	+500	New	+$4.46K	﹤0.01%	802

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

SPC

Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Financial Architects (New Jersey)'s PDLI Position: Q3 2020 in Review

Financial Architects (New Jersey) sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 500 shares — an estimated $1K sold.

Financial Architects (New Jersey) first reported a position in PDLI in Q2 2014 and held it in 22 quarters. The position peaked at $13K in Q1 2019. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

Financial Architects (New Jersey) reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
Financial Architects (New Jersey) sold 500 PDL BioPharma, Inc. shares in Q3 2020, an estimated $1K.
Financial Architects (New Jersey) first reported a position in PDL BioPharma, Inc. in Q2 2014 and held it in 22 quarters.
Financial Architects (New Jersey)'s PDL BioPharma, Inc. position peaked at $13K in Q1 2019.
132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q3 2020, filed 9 Nov 2020.